User profiles for KEISUKE HINO

Keisuke Hino

周南記念病院
Verified email at med.kawasaki-m.ac.jp
Cited by 21049

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

…, N Sakamoto, M Nakagawa, M Korenaga, K Hino… - Nature …, 2009 - nature.com
The recommended treatment for patients with chronic hepatitis C, pegylated interferon-α (PEG-IFN-α)
plus ribavirin (RBV), does not provide sustained virologic response (SVR) in all …

Japan Society of Hepatology guidelines for sarcopenia in liver disease: Recommendation from the working group for creation of sarcopenia assessment criteria

…, M Shiraki, A Hiramatsu, K Moriya, K Hino… - Hepatology …, 2016 - Wiley Online Library
Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into
primary and secondary types, based on the cause. Primary sarcopenia is mainly aging‐…

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan

…, T Ichida, H Sakugawa, M Sata, N Horiike, K Hino… - Hepatology, 2001 - Elsevier
The geographic distribution of hepatitis B virus (HBV) genotypes in Japan and its clinical
relevance are poorly understood. We studied 731 Japanese patients with chronic HBV infection…

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular …

…, H Aikata, N Izumi, T Yamasaki, S Nojiri, K Hino… - Gut, 2020 - gut.bmj.com
Objective This trial compared the efficacy and safety of transarterial chemoembolisation (TACE)
plus sorafenib with TACE alone using a newly established TACE-specific endpoint and …

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C

…, A Urushihara, K Kiyosawa, M Okuda, K Hino… - Hepatology, 1998 - journals.lww.com
To elucidate the risk factors for liver carcinogenesis and to examine the incidence of
hepatocellular carcinoma (HCC) after interferon therapy, 1,022 chronic hepatitis C patients treated …

Hepatitis C virus–induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription

S Nishina, K Hino, M Korenaga, C Vecchi… - Gastroenterology, 2008 - Elsevier
BACKGROUND & AIMS: Despite abundant clinical evidence, the mechanisms by which
hepatic iron overload develops in patients with hepatitis C virus (HCV)-associated chronic liver …

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma …

…, H Nagano, E Hatano, Y Sasaki, K Hino… - The lancet …, 2018 - thelancet.com
Background Hepatic arterial infusion chemotherapy plus sorafenib in phase 2 trials has
shown favourable tumour control and a manageable safety profile in patients with advanced, …

[PDF][PDF] Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection

…, S Kakumu, T Okanoue, Y Murawaki, K Hino… - …, 2006 - Wiley Online Library
The outcome of acute hepatitis B virus (HBV) infection is variable, influenced by host and
viral factors. From 1982 through 2004, 301 patients with acute HBV infection entered a multi‐…

Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial

…, N Toda, T Ide, M Yanase, K Hino… - Journal of Viral …, 2014 - Wiley Online Library
Genotype 2 hepatitis C virus ( HCV ) accounts for up to 30% of chronic HCV infections in
Japan. The standard of care for patients with genotype 2 HCV – peginterferon and ribavirin for …

Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease

…, T Miyake, A Kuno, Y Imai, Y Sawai, K Hino… - Journal of …, 2015 - Springer
Background Accurately evaluating liver fibrosis in patients with non-alcoholic fatty liver disease
(NAFLD) is important for identifying those who may develop complications. The aims of …